Vitronectin promotes the vascularization of porous polyethylene biomaterials
Source abstract
Abstract
Rapid implant vascularization is a prerequisite for successful biomaterial engraftment. Vitronectin (VN) is a matricellular glycoprotein well known for its capability to interact with growth factors, proteases, and protease inhibitors/receptors. Since such proteins are highly relevant for angiogenic processes, we hypothesized that VN contributes to the tissue integration of biomaterials. Employing different in vivo and ex vivo microscopy techniques, engraftment of porous polyethylene (PPE) implants was analyzed in the dorsal skinfold chamber model in wild-type (WT) and VN-/- mice. Upon PPE implantation, vascularization of this biomaterial was severely compromised in animals lacking this matricellular protein. Proteome profiling revealed that VN deficiency does not cause major changes in angiogenic protein composition in the implants suggesting that VN promotes PPE vascularization via mechanisms modulating the activity of angiogenic factors rather than by directly enriching them in the implant. Consequently, surface coating with recombinant VN (embedded in Matrigel®) accelerated implant vascularization in WT mice by enhancing the maturation of a vascular network. Thus, VN contributes to the engraftment of PPE implants by promoting the vascularization of this biomaterial. Surface coating with VN might provide a promising strategy to improve the vascularization of PPE implants without affecting the host's integrity. STATEMENT OF SIGNIFICANCE: Porous polyethylene (PPE) is a biomaterial frequently used in reconstructive surgery. The proper vascularization of PPE implants is a fundamental prerequisite for its successful engraftment in host tissue. Although the overall biocompatibility of PPE is good, there are less favorable application sites for its use in tissue reconstruction mostly characterized by low blood supply. Employing advanced in vivo microscopy methods and proteomic analyses in genetically engineered mice, we here describe a previously unrecognized function of vitronectin (VN) that enables this abundantly present glycoprotein to particularly promote the vascularization of PPE biomaterial. These properties of VN specifically facilitate the formation of a dense vessel network within the implant which relies on modulating the activity of angiogenic mediators rather than on the enrichment of these factors in the implant. Consequently, surface coating with this matricellular protein effectively accelerated and intensified implant vascularization which might be beneficial for its implementation at unfavorable sites for implantation without affecting the host's integrity.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Angiogenesis and VEGF in Cancer · Electrospun Nanofibers in Biomedical Applications · Reconstructive Surgery and Microvascular Techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (49)
Show source-provided references
1. Biomaterials for reconstruction of the internal orbit10.1016/j.coms.2012.07.002 ↗
2. Ear reconstruction with porous polyethylene implants
3. Porous polyethylene in reconstructive head and neck surgery10.1001/archotol.1985.00800050048005 ↗
4. Craniofacial reconstruction with high-density porous polyethylene implants10.1097/00001665-200409000-00004 ↗
5. Effects of presurgical and post-surgical irradiation on the healing process of Medpor in dogs10.1054/ijom.2001.0104 ↗
6. Porous polyethylene implants in revision rhinoplasty: chances and risks
7. Vitronectin in vascular context: facets of a multitalented matricellular protein10.1055/s-0031-1276590 ↗
8. Vitronectin–master controller or micromanager?10.1002/iub.1203 ↗
9. Responses of keratinocytes to substrate-bound vitronectin: growth factor complexes10.1016/j.yexcr.2005.01.004 ↗
10. Molecular interactions and functional interference between vitronectin and transforming growth factor-beta10.1038/labinvest.3780393 ↗
11. Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system10.1002/(SICI)1097-0215(19970328)71:1<116::AID-IJC19>3.0.CO;2-G ↗
12. Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor-urokinase complexes10.1182/blood.V91.7.2305 ↗
13. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions10.1371/journal.pone.0037195 ↗
14. Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity10.1073/pnas.1635112100 ↗
15. Vitronectin regulation of vascular endothelial growth factor-mediated angiogenesis10.1159/000360085 ↗
16. Components of the plasminogen activation system promote engraftment of porous polyethylene biomaterial via common and distinct effects10.1371/journal.pone.0116883 ↗
17. Sucralfate and basic fibroblast growth factor promote endothelial cell proliferation around porous alloplastic implants in vitro10.1097/00002341-199612000-00004 ↗
18. Effect of basic fibroblast growth factor on fibrovascular ingrowth into porous polyethylene anophthalmic socket implants10.3341/kjo.2005.19.1.1 ↗
19. Epidermal and fibroblast growth factors enhance fibrovascular integration of porous polyethylene implants10.1097/00002341-200009000-00006 ↗
20. Biocompatibility of porous polyethylene implants tissue-engineered by extracellular matrix and VEGF10.1002/jbm.a.32670 ↗
21. Vitronectin is not essential for normal mammalian development and fertility10.1073/pnas.92.26.12426 ↗
22. The dorsal skinfold chamber: window into the dynamic interaction of biomaterials with their surrounding host tissue10.22203/eCM.v022a12 ↗
23. Dorsal skinfold chamber technique for intravital microscopy in nude mice
24. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes10.1089/ten.2006.12.2093 ↗
25. Vitalization of porous polyethylene (Medpor(R)) with chondrocytes promotes early implant vascularization and incorporation into the host tissue10.1089/ten.tea.2011.0340 ↗
26. Structural adaptation of normal and tumour vascular networks10.1111/j.1742-7843.2011.00815.x ↗
27. Mechanisms of angiogenesis and arteriogenesis10.1038/74651 ↗
28. Molecular mechanisms and clinical applications of angiogenesis10.1038/nature10144 ↗
29. Clinical and histologic response of subcutaneous expanded polytetrafluoroethylene (Gore-Tex) and porous high-density polyethylene (Medpor) implants to acute and early infection10.1001/archotol.1997.01900030110014 ↗
30. Vitronectin deficiency is associated with increased wound fibrinolysis and decreased microvascular angiogenesis in mice10.1067/msy.2000.105858 ↗
31. A comparison of the adsorption of three adhesive proteins to biomaterial surfaces10.1163/156856292X00060 ↗
32. Accelerating the early angiogenesis of tissue engineering constructs in vivo by the use of stem cells cultured in matrigel
33. Facial skeletal reconstruction using porous polyethylene implants10.1097/01.PRS.0000056866.80665.7A ↗
34. Molecular regulation of vessel maturation10.1038/nm0603-685 ↗
35. Vascular-specific growth factors and blood vessel formation10.1038/35025215 ↗
36. Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors10.1016/j.biomaterials.2013.08.007 ↗
37. Novel hepatocyte growth factor (HGF) binding domains on fibronectin and vitronectin coordinate a distinct and amplified Met-integrin induced signalling pathway in endothelial cells10.1186/1471-2121-6-8 ↗
38. Involvement of vitronectin in lipopolysaccaride-induced acute lung injury10.4049/jimmunol.179.10.7079 ↗
39. Expression of angiostatin, integrin alphavbeta3, and vitronectin in human lungs in sepsis10.1080/01902140500324901 ↗
40. Pre-operative in vitro fibroblast coating of porous polyethylene compound grafts – cell survival in vivo and effects on biocompatibility
41. Tissue engineered cartilage “bioshell” protective layer for subcutaneous implants10.1016/j.ijporl.2006.11.025 ↗
42. The survival of freely grafted orbital fat on porous polyethylene orbital implants in the rabbit10.3341/kjo.2006.20.3.143 ↗
43. Vascularisation of porous scaffolds is improved by incorporation of adipose tissue-derived microvascular fragments10.22203/eCM.v024a19 ↗
44. Pre-cultivation of adipose tissue-derived microvascular fragments in porous scaffolds does not improve their in vivo vascularisation potential10.22203/eCM.v029a14 ↗
45. The Turkish delight: a pliable graft for rhinoplasty10.1097/00006534-200005000-00051 ↗
46. Modified Turkish delight: morcellized polyethylene dorsal graft for rhinoplasty10.1016/j.ijom.2011.03.013 ↗
47. Locally applied macrophage-activating lipopeptide-2 (MALP-2) promotes early vascularization of implanted porous polyethylene (Medpor(R))10.1016/j.actbio.2014.07.004 ↗
48. The role of growth factor signaling in malignancy10.1007/0-306-48158-8_2 ↗
49. Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance10.1016/j.gendis.2014.10.004 ↗